Detalhe da pesquisa
1.
Accuracy of FDG-PET/CT for Response Evaluation of Muscle-Invasive Bladder Cancer following Neoadjuvant or Induction Chemotherapy.
Urol Int
; 107(3): 239-245, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657430
2.
High total metabolic tumor volume at baseline predicts survival independent of response to therapy.
Blood
; 135(16): 1396-1405, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31978225
3.
A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohort.
BMC Public Health
; 21(1): 432, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33653294
4.
Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.
Br J Haematol
; 189(1): 84-96, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31702836
5.
A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.
Blood
; 132(1): 49-58, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29666118
6.
Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.
Blood
; 128(25): 2941-2948, 2016 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27729323
7.
Treatment emergent peripheral neuropathy in the CASSIOPEIA trial.
Haematologica
; 107(7): 1726-1730, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35295081
8.
FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.
Hematol Oncol
; 35(4): 447-455, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27282998
9.
Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study.
Am J Hematol
; 91(4): 410-5, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26799234
10.
Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.
Lancet Oncol
; 14(6): 525-33, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23578722
11.
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Blood Adv
; 8(2): 296-308, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874913
12.
Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patients.
Transfusion
; 53(1): 115-22, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22563760
13.
Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study.
Am J Hematol
; 93(4): E84-E86, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29266414
14.
Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis.
Blood Adv
; 7(15): 3968-3977, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36716220
15.
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
J Clin Oncol
; 41(19): 3523-3533, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071836
16.
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 12(5): 460-8, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21482186
17.
Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial.
Blood Adv
; 6(24): 6169-6179, 2022 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737565
18.
Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.
Haematologica
; 96(8): 1136-43, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21546499
19.
Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study.
Haematologica
; 96(8): 1128-35, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21486862
20.
Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial.
Haematologica
; 100(2): e56-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25398832